KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Total Current Liabilities (2016 - 2026)

Bio-Rad Laboratories has reported Total Current Liabilities over the past 18 years, most recently at $917.0 million for Q1 2026.

  • Quarterly Total Current Liabilities rose 81.01% to $917.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $917.0 million through Mar 2026, up 81.01% year-over-year, with the annual reading at $517.0 million for FY2025, 10.52% up from the prior year.
  • Total Current Liabilities was $917.0 million for Q1 2026 at Bio-Rad Laboratories, up from $517.0 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $917.0 million in Q1 2026 and troughed at $466.2 million in Q1 2024.
  • The 5-year median for Total Current Liabilities is $548.9 million (2025), against an average of $563.8 million.
  • Year-over-year, Total Current Liabilities dropped 20.94% in 2024 and then skyrocketed 81.01% in 2026.
  • A 5-year view of Total Current Liabilities shows it stood at $568.7 million in 2022, then fell by 8.07% to $522.8 million in 2023, then decreased by 10.52% to $467.8 million in 2024, then rose by 10.52% to $517.0 million in 2025, then skyrocketed by 77.37% to $917.0 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Total Current Liabilities are $917.0 million (Q1 2026), $517.0 million (Q4 2025), and $522.3 million (Q3 2025).